Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VUZE System

K-Number: K210830 · 2022-01-03

ApplicantVuze Medical , Ltd.
Decision Date2022-01-03
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

VUZE System is a medical device manufactured by Vuze Medical , Ltd.. It received FDA 510(k) clearance on 2022-01-03 under approval number K210830. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VUZE System?

VUZE System is a medical device that received FDA 510(k) clearance on 2022-01-03. It is manufactured by Vuze Medical , Ltd.. The 510(k) number is K210830.

When was VUZE System approved by the FDA?

VUZE System received FDA 510(k) clearance on 2022-01-03, under approval number K210830.

What company makes VUZE System?

VUZE System is manufactured by Vuze Medical , Ltd..

What is the FDA product code for VUZE System?

The FDA product code for VUZE System is LLZ.

Other Devices by Vuze Medical , Ltd.

K232976VUZE System

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑